Inventor · disambiguated record
Motoo Yamasaki
Also filed as: YAMASAKI MOTOO
77 granted patents·15 pending applications·2,457 citations·filing 1989–2022
99Inventor score
Top patents by PatentIndex Score
92 records- 0199US7214775B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KOGYO KK·Filed 2005·Granted May 8, 2007·363 cites·7 claims
- 0298US7737325B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 15, 2010·55 cites·14 claims
- 0398US7708992B2Methods for producing antibody compositions with increased ADCCKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted May 4, 2010·51 cites·16 claims
- 0498US7651688B2Method of modulating the activity of functional immune molecules to CD52KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jan 26, 2010·47 cites·3 claims
- 0598US7425446B2Antibody composition-producing cellKYOWA HAKKO KOGYO KK·Filed 2005·Granted Sep 16, 2008·93 cites·6 claims
- 0698US7393683B2Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferaseKYOWA HAKKO KOGYO KK·Filed 2005·Granted Jul 1, 2008·63 cites·6 claims
- 0798US6946292B2Cells producing antibody compositions with increased antibody dependent cytotoxic activityKYOWA HAKKO KOGYO KK·Filed 2001·Granted Sep 20, 2005·566 cites·12 claims
- 0897US8067232B2Antibody composition-producing cell with inactivated A-1,6-fusocyltransferaseKANDA YUTAKA·Filed 2008·Granted Nov 29, 2011·45 cites·5 claims
- 0997US7846725B2Antibody composition-producing cell in which enzyme expression is inhibited by RNAiKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Dec 7, 2010·35 cites·6 claims
- 1097US7741442B2Antibody composition exhibiting increased cellular cytotoxicity due to glycosylationKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 22, 2010·32 cites·4 claims
- 1197US7718175B2Method of modulating the activity of functional immune molecules to interleukin-5 receptor proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 18, 2010·32 cites·3 claims
- 1297US7687061B2Method of modulating the activity of functional immune molecules to Her-2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 30, 2010·29 cites·3 claims
- 1397US7682610B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·33 cites·3 claims
- 1496US7763246B2Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptorKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jul 27, 2010·23 cites·3 claims
- 1596US7708997B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 4, 2010·24 cites·3 claims
- 1696US7682611B2Method of modulating the activity of functional immune molecules to CXCR4 proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·26 cites·3 claims
- 1796US7655228B2Method of modulating the activity of functional immune molecules to GM2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Feb 2, 2010·24 cites·3 claims
- 1896US6989145B2Recombinant antibody and antibody fragmentKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jan 24, 2006·93 cites·37 claims
- 1993US7666418B2Method for treating Th2-mediated diseaseKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Feb 23, 2010·22 cites·32 claims
- 2093US5214132APolypeptide derivatives of human granulocyte colony stimulating factorKYOWA HAKKO KOGYO KK·Filed 1989·Granted May 25, 1993·128 cites·1 claims
- 2192US8039595B2Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Oct 18, 2011·9 cites·5 claims
- 2290US8679491B2Method of modulating the activity of functional immune moleculesHANAI NOBUO·Filed 2009·Granted Mar 25, 2014·12 cites·2 claims
- 2390US7064191B2Process for purifying antibodyKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jun 20, 2006·89 cites·8 claims
- 2490US5362853APolypeptide derivatives of human granulocyte colony stimulating factorKYOWA HAKKO KOGYO KK·Filed 1992·Granted Nov 8, 1994·81 cites·2 claims
- 2589US8101185B2Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylationKANDA YUTAKA·Filed 2010·Granted Jan 24, 2012·6 cites·4 claims
- 2689US6245900B1Platelet production promoting agentKYOWA HAKKO KOGYO KK·Filed 1995·Granted Jun 12, 2001·84 cites·2 claims
- 2789US5681720ADNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptideKYOWA HAKKO KOGYO KK·Filed 1995·Granted Oct 28, 1997·53 cites·17 claims
- 2888US6103236AToxin conjugatesKYOWA HAKKO KOGYO KK·Filed 1996·Granted Aug 15, 2000·79 cites·11 claims
- 2987US11478551B2Long-acting adrenomedullin derivativeUNIV MIYAZAKI·Filed 2020·Granted Oct 25, 2022·1 cites·18 claims
- 3087US9150639B2Antibody and antibody fragment introduced new modification sitesYAMASAKI MOTOO·Filed 2011·Granted Oct 6, 2015·10 cites·14 claims
- 3187US8895266B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2012·Granted Nov 25, 2014·4 cites·4 claims
- 3287US8158760B2Glycoengineered, recombinant antibodyKANDA YUTAKA·Filed 2009·Granted Apr 17, 2012·4 cites·4 claims
- 3386US8329443B2Antibody composition-producing cellKANDA YUTAKA·Filed 2011·Granted Dec 11, 2012·4 cites·4 claims
- 3486US8110195B2Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibodyKANDA YUTAKA·Filed 2010·Granted Feb 7, 2012·4 cites·4 claims
- 3584US5795968APolypeptide derivatives of human granulocyte colony stimulating factorKYOWA HAKKO KOGYO KK·Filed 1997·Granted Aug 18, 1998·35 cites·8 claims
- 3683US10233247B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Mar 19, 2019·2 cites·6 claims
- 3783US6027720AG-CSF conjugateKYOWA HAKKO KOGYO KK·Filed 1994·Granted Feb 22, 2000·49 cites·8 claims
- 3882US8632996B2Method for producing recombinant antibody and antibody fragment thereofSHITARA KENYA·Filed 2012·Granted Jan 21, 2014·4 cites·28 claims
- 3981US6884419B1hG-CSF fusion polypeptide having c-mpl activity, DNA coding for same and methods of treating anemia using sameKYOWA HAKKO KOGYO KK·Filed 2000·Granted Apr 26, 2005·8 cites·9 claims
- 4080US12171836B2Long-acting adrenomedullin derivativeUNIV MIYAZAKI·Filed 2022·Granted Dec 24, 2024·0 cites·16 claims
- 4180US6638509B1Toxin conjugatesKYOWA HAKKO KOGYO KK·Filed 2000·Granted Oct 28, 2003·8 cites·4 claims
- 4279US8197814B2Method for treating the Th2-mediated diseaseSHITARA KENYA·Filed 2010·Granted Jun 12, 2012·3 cites·32 claims
- 4376US10842879B2Long-acting adrenomedullin derivativeUNIV MIYAZAKI·Filed 2016·Granted Nov 24, 2020·1 cites·14 claims
- 4474US2019360015A1Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 4574US2010143388A1Antibody Composition-Producing CellKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 4674US2020017593A1Method of producing antibodies with n-glycoside-linked sugar chains lacking fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 4773US8367407B2Cells with altered fucosylation and producing antibodies therefromKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Feb 5, 2013·0 cites·14 claims
- 4872US9409982B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Aug 9, 2016·0 cites·7 claims
- 4968US10233475B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2016·Granted Mar 19, 2019·0 cites·20 claims
- 5067US2017240647A1Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2017·Application pending·0 cites
Showing the top 50 of 92 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →